The frequency of SEMA3B promoter hypermethylation (44–52%) is approximately two times lower than the frequency of expression decreases (84–95% cases, according to semi-quantitative PCR data) in NSCLC and ccRCC. The gene discussed is SEMA3B; the disease is nonpapillary renal cell carcinoma.